1
|
Nie YC, Yin ZH, Hua F, Yan L, Xue YJ, Ma YT, Yao ZG. Two Chinese cases of cutaneous squamous cell carcinoma in patients with Lynch syndrome. Pathology 2024:S0031-3025(24)00090-4. [PMID: 38604896 DOI: 10.1016/j.pathol.2024.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 12/30/2023] [Accepted: 01/08/2024] [Indexed: 04/13/2024]
Affiliation(s)
- Yi-Cong Nie
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Zuo-Hua Yin
- Department of Pathology, The People's Hospital of Huaiyin, Jinan, China
| | - Fang Hua
- Department of Microbiology and Immunology, Tulane University, New Orleans, LA, USA
| | - Li Yan
- Department of Pathology, Dongying City People's Hospital, Dongying, China
| | - Ying-Jie Xue
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Yu-Ting Ma
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
| | - Zhi-Gang Yao
- Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; Department of Pathology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
| |
Collapse
|
2
|
Zhong CS, Horiguchi M, Uno H, Ukaegbu C, Chittenden A, LeBoeuf NR, Syngal S, Nambudiri VE, Yurgelun MB. Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. J Am Acad Dermatol 2023; 88:1282-1290. [PMID: 36773823 PMCID: PMC10238628 DOI: 10.1016/j.jaad.2023.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2022] [Revised: 01/09/2023] [Accepted: 01/27/2023] [Indexed: 02/11/2023]
Abstract
BACKGROUND Little is known about patient-specific risk factors for skin neoplasia in individuals with Lynch syndrome (LS). OBJECTIVE Identify clinical factors associated with development of skin neoplasms in LS. METHODS Clinical data were systematically collected on a cohort of LS carriers (confirmed pathogenic germline variants in MLH1, MSH2, MSH6, PMS2, or EPCAM) age ≥18 undergoing clinical genetics care at Dana-Farber Cancer Institute from January 2000 to March 2020. Multivariable logistic regression was performed to evaluate clinical factors associated with skin neoplasia. RESULTS Of 607 LS carriers, 9.2% had LS-associated skin neoplasia and 15.0% had non-LS-associated skin neoplasia; 58.2% (353/607) had documentation of prior dermatologic evaluation; 29.7% (38/128) with skin neoplasms lacked a history of visceral LS-associated malignancy. LS-associated skin neoplasms were significantly associated with male sex, age, race, MLH1 pathogenic germline variants, MSH2/EPCAM pathogenic germline variants, and personal history of non-LS skin neoplasms. Non-LS-associated skin neoplasms was significantly associated with age, number of first- and second-degree relatives with non-LS-associated skin neoplasms, and personal history of LS-associated skin neoplasms. LIMITATIONS Single-institution observational study; demographic homogeneity. CONCLUSIONS Skin neoplasms are common in individuals with LS. We identified clinical factors associated with LS- and non-LS-associated skin neoplasms. Regular dermatologic surveillance should be considered for all LS carriers.
Collapse
Affiliation(s)
- Connie S Zhong
- Brigham & Women's Hospital, Department of Dermatology, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts
| | - Miki Horiguchi
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Division of Population Sciences, Department of Medical Oncology, Boston, Massachusetts
| | - Hajime Uno
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Division of Population Sciences, Department of Medical Oncology, Boston, Massachusetts
| | - Chinedu Ukaegbu
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Division of Population Sciences, Department of Medical Oncology, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cancer Genetics and Prevention, Boston, Massachusetts
| | - Anu Chittenden
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cancer Genetics and Prevention, Boston, Massachusetts
| | - Nicole R LeBoeuf
- Brigham & Women's Hospital, Department of Dermatology, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cutaneous Oncology, Boston, Massachusetts
| | - Sapna Syngal
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Division of Population Sciences, Department of Medical Oncology, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cancer Genetics and Prevention, Boston, Massachusetts; Brigham & Women's Hospital, Department of Medicine, Boston, Massachusetts
| | - Vinod E Nambudiri
- Brigham & Women's Hospital, Department of Dermatology, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cutaneous Oncology, Boston, Massachusetts
| | - Matthew B Yurgelun
- Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Division of Population Sciences, Department of Medical Oncology, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Center for Cancer Genetics and Prevention, Boston, Massachusetts; Brigham & Women's Hospital, Department of Medicine, Boston, Massachusetts; Dana-Farber Cancer Institute, Department of Medical Oncology, Gastrointestinal Cancer Center, Boston, Massachusetts.
| |
Collapse
|
3
|
Ykema BLM, Adan F, Crijns MB, Bleeker FE, Dekker E, Bekkenk MW, Snaebjornsson P, van Leerdam ME. Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome-associated tumours. Br J Dermatol 2021; 185:462-463. [PMID: 33829484 DOI: 10.1111/bjd.20139] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 04/02/2021] [Accepted: 04/02/2021] [Indexed: 12/25/2022]
Affiliation(s)
- B L M Ykema
- Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - F Adan
- Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - M B Crijns
- Department of Dermatology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - F E Bleeker
- Department of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - E Dekker
- Department of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, the Netherlands
| | - M W Bekkenk
- Department of Dermatology, Academic Medical Centre, Amsterdam, the Netherlands
| | - P Snaebjornsson
- Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands
| | - M E van Leerdam
- Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, the Netherlands.,Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands
| |
Collapse
|
4
|
Moorthy V, Sanku K, Singh HP, Khillan R, Patel PP. Cutaneous Squamous Cell Carcinoma in Lynch Syndrome - An Overlooked Association. Cureus 2021; 13:e13553. [PMID: 33654645 PMCID: PMC7916637 DOI: 10.7759/cureus.13553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Lynch syndrome is an autosomal dominant disorder caused by germline mutation affecting mismatch-repair genes. Genetic testing is performed selectively. Diagnosed individuals are to undergo surveillance to detect and manage Lynch syndrome-related cancers early in the course. Muir-Torre syndrome is a phenotypic variant of Lynch syndrome characterized by sebaceous neoplasms, keratoacanthoma, or both in addition to other Lynch syndrome-related cancers. Other neoplasms of the skin, such as squamous cell carcinoma, are not recognized as part of the Lynch syndrome tumor-spectrum. We report a case of cutaneous squamous cell carcinoma occurring in a patient with Lynch syndrome and explore some of the characteristic features and significance of this association.
Collapse
Affiliation(s)
- Vivek Moorthy
- Internal Medicine, Kasturba Medical College, Manipal, IND.,Hematology and Oncology, Brooklyn Cancer Care, Brooklyn, USA
| | - Koushik Sanku
- Internal Medicine, Gandhi Medical College, Hyderabad, IND.,Hematology and Oncology, Brooklyn Cancer Care, Brooklyn, USA
| | - Harjinder P Singh
- Internal Medicine, University College of Medical Sciences, New Delhi, IND.,Hematology and Oncology, Brooklyn Cancer Care, Brooklyn, USA
| | - Ratesh Khillan
- Hematology and Oncology, Kingsbrook Jewish Medical Center, New York, USA.,Hematology and Oncology, Brooklyn Cancer Care, Brooklyn, USA
| | - Pathik P Patel
- Internal Medicine, B. J. Medical College, Ahmedabad, IND.,Hematology and Oncology, Brooklyn Cancer Care, Brooklyn, USA
| |
Collapse
|